Prostate Cancer

Disease State Hub

Research Summaries

Prostate cancer

Could Statin Use During ADT Delay Progression of Prostate Cancer?

05/11/2015

New research evaluated rates of prostate cancer development in patients undergoing androgen deprivation therapy and taking statins.

05/11/2015

Prostate cancer

New Guidelines to Treat Advanced Prostate Cancer

09/10/2014

A new set of guidelines provides treatment recommendations for men with metastatic castration-resistant prostate cancer.

09/10/2014

Prostate cancer

Testosterone Therapy Won’t Raise Prostate Cancer Risk

06/13/2014

A new study evaluated the possible risk for prostate cancer in hypogonadal men on long-term testosterone therapy.

06/13/2014

Research Summaries

Research Summary

Research Summary

Darolutamide Monotherapy Lowers PSA in Patients With Hormone-Sensitive Prostate Cancer

02/19/2025

Kate Young

Darolutamide monotherapy reduced prostate-specific antigen response in patients with hormone-sensitive prostate cancer while maintaining testosterone levels in a recent 24-week randomized study.

02/19/2025

Research Summary

Is Overtreatment of Prostate Cancer Still a Concern for Men with Limited Life Expectancy in the Active Surveillance Era?

01/02/2025

Miranda Manier, BA

A new retrospective study examines treatment trends among men with limited life expectancy diagnosed with prostate cancer in the Veterans Affairs health system from 2000 to 2019. Researchers explored...

01/02/2025

Research Summary

Image-Guided Adaptive Radiation Treatments Reduces Short-Term Side Effects in Patients With Prostate Cancer

10/06/2023

Jessica Ganga

A team of researchers compared the presence of short-term side effects using two image-guided radiation treatment—magnetic resonance imaging-guided daily adaptive prostate stereotactic body radiotherapy...

10/06/2023

Conference Coverage

Hypercholesterolemia and Diabetes Have Little Impact on Major Adverse Cardiovascular Events Risk in Patients With Prostate Cancer

05/16/2023

Jessica Bard

Hypercholesterolemia and diabetes have a minimal impact on major adverse cardiovascular events (MACE) risk in patients with prostate cancer (PCa) who are treated with androgen deprivation therapy (ADT),...

05/16/2023

Prostate Cancer

Presurgical NHAs May Improve Outcomes For Patients With High-Risk Prostate Cancer

11/21/2022

The researchers set out to determine whether neoadjuvant novel hormonal agent (NHA) therapy before radical prostatectomy can improve outcomes in men with high-risk prostate cancer.

11/21/2022

March 2025

Current Issue

March 2025

Volume 65

Issue 3